- Home
- ELLO vs SERA Comparison
ELLO vs SERA Comparison
Compare ELLO & SERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELLO
- SERA
- Stock Information
- Founded
- ELLO 1987
- SERA 2008
- Country
- ELLO Israel
- SERA United States
- Employees
- ELLO N/A
- SERA N/A
- Industry
- ELLO Electric Utilities: Central
- SERA Precision Instruments
- Sector
- ELLO Utilities
- SERA Health Care
- Exchange
- ELLO Nasdaq
- SERA Nasdaq
- Market Cap
- ELLO 208.2M
- SERA 208.7M
- IPO Year
- ELLO 1995
- SERA 2021
- Fundamental
- Price
- ELLO $15.60
- SERA $4.12
- Analyst Decision
- ELLO
- SERA
- Analyst Count
- ELLO 0
- SERA 0
- Target Price
- ELLO N/A
- SERA N/A
- AVG Volume (30 Days)
- ELLO 1.7K
- SERA 148.0K
- Earning Date
- ELLO 03-31-2025
- SERA 03-19-2025
- Dividend Yield
- ELLO N/A
- SERA N/A
- EPS Growth
- ELLO N/A
- SERA N/A
- EPS
- ELLO N/A
- SERA N/A
- Revenue
- ELLO $44,850,546.00
- SERA $94,000.00
- Revenue This Year
- ELLO N/A
- SERA N/A
- Revenue Next Year
- ELLO N/A
- SERA $3,081.82
- P/E Ratio
- ELLO N/A
- SERA N/A
- Revenue Growth
- ELLO N/A
- SERA N/A
- 52 Week Low
- ELLO $11.08
- SERA $3.84
- 52 Week High
- ELLO $20.81
- SERA $12.36
- Technical
- Relative Strength Index (RSI)
- ELLO 46.16
- SERA 31.08
- Support Level
- ELLO $15.10
- SERA $3.89
- Resistance Level
- ELLO $16.91
- SERA $4.46
- Average True Range (ATR)
- ELLO 0.76
- SERA 0.43
- MACD
- ELLO -0.01
- SERA -0.00
- Stochastic Oscillator
- ELLO 43.29
- SERA 10.22
About ELLO Ellomay Capital Ltd (Israel)
Ellomay Capital Ltd is focused on the utility sector. It is an Israeli public company, which focuses its business in the energy and infrastructure sectors. The company's operating segment includes Photovoltaic power plants (PV Plants); Dorad Energy Ltd. (Dorad); Groen Gas Goor B.V. and a Pumped storage hydro power plant (Manara). It generates maximum revenue from the Dorad segment. Geographically, it derives a majority of its revenue from Spain.
About SERA Sera Prognostics Inc.
Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services.